Bictegravir

Bictegravir is an HIV integrase strand-transfer inhibitor incorporated into single-tablet antiretroviral regimens, blocking viral DNA integration into the host genome. Simson Pharma's Bictegravir reference standard and impurities support stability-indicating method development for this modern antiretroviral combination.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bictegravir Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Bictegravir
Trifluoro hydroxyl impurity
Methyl Bictegravir
2-fluoro bictegravir
4-Fluoro Bictegravir
2,4-difluoro impurity
Bictegravir Impurity 3
Benzyl impurity
(2R,5S,13aS) isomer
Bictegravir Sodium
Bictegravir Impurity 7
Bictegravir Impurity 6
(1R,3S)-3-Aminocyclopentanol hydrochloride
(1S,3R)-3-Aminocyclopentanol hydrochloride
(1R,3R)-3-aminocyclopentanol
(1S,3S)-3-Aminocyclopentanol
Bictegravir Impurity 5
Bictegravir Enantiomer
Bictegravir Impurity 11
Bictegravir Impurity 12
Bictegravir Impurity 13
Bictegravir Impurity 9
Bictegravir Impurity 8
Bictegravir Impurity 2
Bictegravir Impurity 4
Bictegravir Impurity 10
Bictegravir Impurity 14
Bictegravir Impurity 15
Bictegravir Impurity 16
Bictegravir Impurity 17

Metabolites

Bictegravir Metabolite M15

Isotope Labelled Compounds

Bictegravir 13C,15N-D2
Bictegravir 15N D2
Bictegravir-D5
Bictegravir D5 Isomer
Bictegravir D4